Articles by American Association for Cancer Research

New article outlines best practices, novel statistical methods, and suggestions for improving benefit-risk assessments in clinical trials

Saruparib has higher selectivity for PARP1, improving safety and tolerability compared to existing first-gen PARP inhibitors

When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers

The HER2CLIMB-02 trial reveals significant benefits, especially for breast cancer patients with brain metastases

Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control

Current guidelines ruled 60 percent of individuals identified with HBOC risk as ineligible for genetic testing 

Researchers partnered with Gift Of Life Michigan to analyze healthy pancreata from deceased donors

Comprehensive plan provides an updated roadmap and strategies to end cancer as we know it

Carolyn R. Bertozzi, PhD, is credited for inventing biorthogonal chemistry and “copper-free click chemistry”

Resource reflects transition from a mostly microscopy-driven to a molecularly driven classification system

Genetic alterations in CTCs were associated with resistance to hormone therapy in castrate-resistant prostate cancer

Cost-effective sequencing method is an ideal technique for sample analysis, researchers note

Approximately 40 percent of melanomas lack sufficient infiltration of immune cells within the tumor and therefore have poor responses to immunotherapies

Studies have suggested an increase in infections prior to the development of non-solid tumors, but few studies have examined if this is also the case with solid tumors

In a recent study, researchers aimed to train cutting-edge AI technologies to predict patients' responses to treatment